喀什包皮过长该怎样治喀什做打胎手术好的医院,喀什早孕后多久可以测出,喀什长期勃起不硬看哪个科,喀什三个月还能做人流吗,喀什哪个医院无痛人流手术好,喀什流产哪间医院好,喀什专业不要孩子医院哪家好

The Federal Bureau of Investigation said in an email to E.W. Scripps that a civil rights investigation has been opened into the fatal shooting of an Overland Park, Kansas, teen by a police officer.FBI spokeswoman Bridget Patton said the Kansas City Field FBI Field Office, the Civil Rights Division, and the US Attorney's office for the District of Kansas are looking into the death of John Albers, who was fatally shot in January 2018.According to USA Today, Albers was backing out of his family's garage towards former Overland Park officer Clayton Jenison, who yelled him to stop and then fired 13 times.The shooting was later ruled justified by the Johnson County District Attorney, USA Today reported.After the shooting, Albers' family settled a wrongful death lawsuit against the city for .3 million."The FBI will collect all available facts and evidence and will ensure that the investigation is conducted in a fair, thorough, and impartial manner," Patton said. 979

The Ebola virus outbreak in the Democratic Republic of Congo has killed 33 people, the World Health Organization said Sunday.An additional 43 suspected cases of Ebola were reported, including 13 confirmed by lab testing, according to WHO.The outbreak is spreading through five health zones in North Kivu province and one health zone in Ituri province, which poses geographic and political challenges, the WHO said. North Kivu borders Rwanda and Uganda and trade activity fuels heavy movement across the borders.North Kivu also hosts over 1 million displaced people and fighting between government forces and armed militant groups makes containing the highly infectious virus a challenge. 695

The Food and Drug Administration’s Vaccines and Related Biological Products Advisory Committee has endorsed Pfizer’s coronavirus vaccine, in a major step toward an epic vaccination campaign that could finally conquer the outbreak. The group, in a 17-4 vote with one abstention, concluded that the shot appears safe and effective against the coronavirus in people 16 and older.The Food and Drug Administration is expected to follow the recommendation issued Thursday by its expert advisers. A final FDA decision is expected within days. The vaccine had already been authorization by officials in Canada and the UK.An emergency use authorization allows practitioners to administer a vaccine despite it not gaining full FDA approval. The EUA means that the vaccine is allowed to be used in non-clinical settings, which would allow Americans not in a trial or hospital setting to get the vaccine.Millions of shots would then ship to begin vaccinating health care workers and nursing home residents, but the Centers for Disease Control and Prevention will need to formally recommend the vaccine before health care officials can begin distributing the shots.Once it is authorized, it is expected that several million doses of the vaccine will immediately begin being distributed throughout the US to high-risk individuals. The first group of those expected to be inoculated includes health care workers and those who live or work in assisted living facilities.“The FDA recognizes that transparency and dialogue are critical for the public to have confidence in COVID-19 vaccines. I want to assure the American people that the FDA’s process and evaluation of the data for a potential COVID-19 vaccine will be as open and transparent as possible,” said FDA Commissioner Stephen M. Hahn, M.D. “The FDA has been preparing for the review of EUAs for COVID-19 vaccines for several months and stands ready to do so as soon as a EUA request is submitted. While we cannot predict how long the FDA’s review will take, the FDA will review the request as expeditiously as possible, while still doing so in a thorough and science-based manner, so that we can help make available a vaccine that the American people deserve as soon as possible.”Pfizer says that the vaccine is showing a 95% efficacy against coronavirus infection. It is one of two vaccines that could be approved by the FDA in the next few weeks. Moderna also has a vaccine candidate that is showing the efficacy of 95%.“Our work to deliver a safe and effective vaccine has never been more urgent, as we continue to see an alarming rise in the number of cases of COVID-19 globally. Filing in the U.S. represents a critical milestone in our journey to deliver a COVID-19 vaccine to the world and we now have a more complete picture of both the efficacy and safety profile of our vaccine, giving us confidence in its potential,” said Dr. Albert Bourla, Pfizer Chairman and CEO. “We look forward to the upcoming Vaccines and Related Biological Products Advisory Committee discussion and continue to work closely with the FDA and regulatory authorities worldwide to secure authorization of our vaccine candidate as quickly as possible.”One concern over the Pfizer vaccine is possible side effects on those prone to allergic reactions. The UK’s National Health Service is advising those prone to allergic reactions to not take the Pfizer vaccine as it investigates two health care workers having apparent reactions after receiving the vaccine.Once given authorization, officials will be forced to confront two challenges: Public confidence in the vaccine and distribution. Both the Moderna and Pfizer vaccines are required to be refrigerated until use, complicating distribution methods.Also, polls are showing that a significant number of Americans are hesitant to take the vaccine. Public health experts say getting the vast majority of Americans immunized is important in order to reach herd immunity against the virus and to allow for normalcy to return to the US.In addition to a number of public health experts saying they’ll get the vaccine as a way to instill trust, former Presidents Bill Clinton, George W. Bush, and Barack Obama said they would publicly take the vaccine in order to instill faith in the shot.Widespread access to the general public is not expected until the spring. 4342

The Centers for Disease Control and Prevention is asking people who take a COVID-19 vaccine to download a smartphone app so it can continue to track side effects.The app, called V-Safe, uses text messages and web surveys from the CDC to check in with patients who have gotten a COVID-19 vaccine.The app will also remind patients when it's time to go back for a second shot.Patients can expect to experience mild symptoms like fever, headache and muscle aches after taking the vaccine. But doctors, like Dr. Grace Lee — the associate chief medical officer for practice innovation at Stanford Children's Health and a member of the CDC's vaccine advisory panel — say those side effects don't tend to last very long."We hope that patients will be willing to engage in the system, recognizing it does take some time," Lee said. "But it's really important for all of us in the U.S. to make sure that we are helping to create a robust vaccine safety monitoring system for all COVID vaccines."Lee says that because clinical trials for COVID-19 vaccines have been so large — with 30,000 to 60,000 people in each trial, compared to just several thousand for a typical trial — there's already a lot known about the vaccines.The trials have shown no major safety risks thus far, but Lee says rare adverse events can happen — like the two healthcare workers in Alaska earlier this week who suffered anaphylactic allergic reactions with the Pfizer vaccine. The side effects reported by those two patients were similar to the ones suffered by two people in the U.K. earlier this month.Lee says that's why the CDC is counting on as many people as possible to use V-Safe."My hope is that if the numbers are high," Lee said. "It just means it gives us more information more quickly, and so for anything rare that might occur, we would be able to pick it up much more quickly."V-Safe send text messages to patients, asking them how they are feeling for up to six weeks after their shots. The CDC says the questions take less than five minutes to answer and that the information patients provide will be confidential and private. 2117

The combined jackpots for Mega Millions and Powerball?total more than 0 million right now, and it's possible that will surpass a combined billion.It's one of the highest combined totals ever for the two lottery games.The Mega Millions, with a current jackpot of 9 million, will be drawn at 11 p.m. Eastern today. The Powerball, which is at 4 million, is drawn on Saturday.The highest Mega Millions jackpot ever won was 6 million in 2012. It was split by winners in three states. The largest Powerball payout was 2 million in August 2018. 588